You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 7, August 18, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Review
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (94)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CLINICIAN'S CORNER
Small Intestinal Bacterial Overgrowth

A Framework for Understanding Irritable Bowel Syndrome

Henry C. Lin, MD

JAMA. 2004;292:852-858.

Context  Irritable bowel syndrome (IBS), which affects 11% to 14% of the population, is a puzzling condition with multiple models of pathophysiology including altered motility, visceral hypersensitivity, abnormal brain-gut interaction, autonomic dysfunction, and immune activation. Although no conceptual framework accounts for all the symptoms and observations in IBS, a unifying explanation may exist since 92% of these patients share the symptom of bloating regardless of their predominant complaint.

Evidence Acquisition  Ovid MEDLINE was searched through May 2004 for relevant English-language articles beginning with those related to bloating, gas, and IBS. Bibliographies of pertinent articles and books were also scanned for additional suitable citations.

Evidence Synthesis  The possibility that small intestinal bacterial overgrowth (SIBO) may explain bloating in IBS is supported by greater total hydrogen excretion after lactulose ingestion, a correlation between the pattern of bowel movement and the type of excreted gas, a prevalence of abnormal lactulose breath test in 84% of IBS patients, and a 75% improvement of IBS symptoms after eradication of SIBO. Altered gastrointestinal motility and sensation, changed activity of the central nervous system, and increased sympathetic drive and immune activation may be understood as consequences of the host response to SIBO.

Conclusions  The gastrointestinal and immune effects of SIBO provide a possible unifying framework for understanding frequent observations in IBS, including postprandial bloating and distension, altered motility, visceral hypersensitivity, abnormal brain-gut interaction, autonomic dysfunction, and immune activation.


Author Affiliation: Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome
Timothy King
JAMA. 2004;292(18):2213.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Small intestinal bacterial overgrowth in systemic sclerosis
Marie et al.
Rheumatology (Oxford) 2009;48:1314-1319.
ABSTRACT | FULL TEXT  

The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment
Vanner
Gut 2008;57:1315-1321.
FULL TEXT  

Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome
Goebel et al.
Rheumatology (Oxford) 2008;47:1223-1227.
ABSTRACT | FULL TEXT  

Rifaximin Treatment for Symptoms of Irritable Bowel Syndrome
Fumi and Trexler
The Annals of Pharmacotherapy 2008;42:408-412.
ABSTRACT | FULL TEXT  

Update: A 54-Year-Old Woman With Constipation-Predominant Irritable Bowel Syndrome
Farag et al.
JAMA 2008;299:88-88.
FULL TEXT  

Translating symptoms into mechanisms: functional GI disorders
Collins
Adv. Physiol. Educ. 2007;31:329-331.
ABSTRACT | FULL TEXT  

Probiotics in Irritable Bowel Syndrome: An Immunomodulatory Strategy?
Quigley
J. Am. Coll. Nutr. 2007;26:684S-690S.
ABSTRACT | FULL TEXT  

Synergy between Lactobacillus paracasei and Its Bacterial Products to Counteract Stress-Induced Gut Permeability and Sensitivity Increase in Rats
Eutamene et al.
J. Nutr. 2007;137:1901-1907.
ABSTRACT | FULL TEXT  

Evidence of Prolonged Orocecal Transit Time and Small Intestinal Bacterial Overgrowth in Acromegalic Patients
Resmini et al.
J. Clin. Endocrinol. Metab. 2007;92:2119-2124.
ABSTRACT | FULL TEXT  

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
Posserud et al.
Gut 2007;56:802-808.
ABSTRACT | FULL TEXT  

Treating Irritable Bowel Syndrome with a Food Elimination Diet Followed by Food Challenge and Probiotics
Drisko et al.
J. Am. Coll. Nutr. 2006;25:514-522.
ABSTRACT | FULL TEXT  

Treatment for bacterial overgrowth in the irritable bowel syndrome.
Drossman
ANN INTERN MED 2006;145:626-628.
FULL TEXT  

A 54-Year-Old Woman With Constipation-Predominant Irritable Bowel Syndrome
Lembo
JAMA 2006;295:925-933.
FULL TEXT  

Nutrition Aspects of Gastroparesis and Therapies for Drug-Refractory Patients
Abell et al.
Nutr Clin Pract 2006;21:23-33.
ABSTRACT | FULL TEXT  

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome
King
JAMA 2004;292:2213-2213.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.